Background Type 2 diabetes mellitus (T2DM) is a condition characterized by insulin resistance and progressive failure of the insulin-secreting beta-cells. Based on studies in small cohorts of young patients (especially Pima Indian offspring), we know that individuals with childhood onset T2DM are at very high risk for diabetes-related morbidity and mortality, due to a longer life-time duration of diabetes, as well as possible increased rapidity of beta-cell failure. Our primary study objective is to acquire data on the natural history of T2DM in youth. Measurements will include indices of beta-cell function, body composition, cardiovascular disease risk factors, gut hormones, and psychological well-being. These data will be compared to findings in non-diabetic volunteers who are lean or overweight/obese. Data from several recent epidemiologic studies have indicated a link between diet soda consumption, obesity, and even type 2 diabetes. However, there is no evidence for a causal relationship. Artificial sweeteners have long been regarded as metabolically inert substances since they contain no or very few calories. Yet, data from rodent studies show that artificial sweeteners may have distinct effects on glucoregulatory hormones and our previous pilot study has confirmed a greater responsiveness of GLP-1 when a glucose meal was preceded by diet soda. We plan to further characterize effects of consumption of artificial sweeteners on intestinal and will enroll healthy volunteers, as well as subjects with type 1 and type 2 diabetes. These subjects will undergo repeated oral glucose tolerance tests or mixed meal tests, preceded by consumption of a water or a sucralose-containing diet soda. We will investigate differences in insulin, glucose, or other hormone levels between the repeated tests.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
Blau, J E; Abegg, M R; Flegel, W A et al. (2015) Long-term immunosuppression after solitary islet transplantation is associated with preserved C-peptide secretion for more than a decade. Am J Transplant 15:2995-3001
Taylor, Simeon I; Blau, Jenny E; Rother, Kristina I (2015) SGLT2 Inhibitors May Predispose to Ketoacidosis. J Clin Endocrinol Metab 100:2849-52
Taylor, Simeon I; Blau, Jenny E; Rother, Kristina I (2015) Possible adverse effects of SGLT2 inhibitors on bone. Lancet Diabetes Endocrinol 3:8-10
Cizza, Giovanni; Piaggi, Paolo; Rother, Kristina I et al. (2014) Hawthorne effect with transient behavioral and biochemical changes in a randomized controlled sleep extension trial of chronically short-sleeping obese adults: implications for the design and interpretation of clinical studies. PLoS One 9:e104176
Cizza, Giovanni; de Jonge, Lilian; Piaggi, Paolo et al. (2014) Neck circumference is a predictor of metabolic syndrome and obstructive sleep apnea in short-sleeping obese men and women. Metab Syndr Relat Disord 12:231-41
Sarkar, Gayatri; Alattar, May; Brown, Rebecca J et al. (2014) Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes Care 37:666-70
Sarkar, Gayatri; Alattar, May; Brown, Rebecca J et al. (2014) Response to comment on Sarkar et al. Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes care 2014;37:666-670. Diabetes Care 37:e219-20
Lucassen, Eliane A; Zhao, Xiongce; Rother, Kristina I et al. (2013) Evening chronotype is associated with changes in eating behavior, more sleep apnea, and increased stress hormones in short sleeping obese individuals. PLoS One 8:e56519
Cizza, Giovanni; Piaggi, Paolo; Lucassen, Eliane A et al. (2013) Obstructive sleep apnea is a predictor of abnormal glucose metabolism in chronically sleep deprived obese adults. PLoS One 8:e65400
Brown, Rebecca J; Walter, Mary; Rother, Kristina I (2012) Effects of diet soda on gut hormones in youths with diabetes. Diabetes Care 35:959-64

Showing the most recent 10 out of 19 publications